PharmaBiome Company
PharmaBiome is specialized in the isolation, characterization, and technology of novel intestinal microbes. Their technology platform optimizes the lean and efficient development and production of defined, function-based microbiome therapies to treat intestinal diseases.
PharmaBiome’s proprietary development pipeline allows a fast translation from the identification of mode of action to a product ready for clinics, using tailored, ecologically sound bacterial mixtures.
Employee Number:
1-10
Headquarters:
Zürich, Zurich, Switzerland, Europe
Founded Date:
2015-01-01
Industry:
Cell, Gene & Biologics Therapeutics
Super Industry:
Biopharma & Life Science Tools
Investors:
BaseLaunch, EISMEA, Venture Kick
Ipo Status:
private
City:
Zürich
Region:
Zurich
Country:
Switzerland
Founders:
Tomas de Wouters




